Esther Maria Furrer

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Tillotts Pharma Ag, Tillotts Pharm Ag, University College London. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esther Maria Furrer. Retrieved from https://idiyas.com/inventor/esther-maria-furrer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

University College London

patents

where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12215146 - Antibody variants (2025-02-04),

2. 12209122 - Anti-TNF-alpha-antibodies and functional fragments thereof (2025-01-28),

3. 12043663 - Anti-TNF-alpha-antibodies and functional fragments thereof (2024-07-23),

4. 11999781 - Antibody variants (2024-06-04),

5. 11717484 - Topical treatment of inflammatory bowel disease using antibodies and fragments thereof (2023-08-08),

6. 11472872 - Antibody variants (2022-10-18),

7. 11459383 - Anti-TNF-alpha-antibodies and functional fragments thereof (2022-10-04),

8. 10975143 - Anti-TNF-α-antibodies and functional fragments thereof (2021-04-13),

Title: Esther Maria Furrer: Innovator in Antibody Research

Introduction

Esther Maria Furrer is a prominent inventor based in Rheinfelden, Switzerland. She has made significant contributions to the field of antibody research, holding a total of eight patents. Her work focuses on developing innovative antibody variants with enhanced properties for therapeutic applications.

Latest Patents

Among her latest patents, one invention relates to antibody variants that bind to TNFα and exhibit modified FcRn-binding. These antibodies demonstrate good effector functions and pharmacokinetic properties. Another notable patent involves anti-TNF-alpha-antibodies and their functional fragments, which are capable of binding to tumor necrosis factor alpha (TNFα). This patent also covers the processes for their production and their therapeutic uses.

Career Highlights

Esther has worked with notable companies in the pharmaceutical industry, including Tillotts Pharma AG and Tillotts Pharm AG. Her expertise in antibody development has positioned her as a key player in advancing therapeutic solutions for various diseases.

Collaborations

Esther has collaborated with talented professionals in her field, including Tea Gunde and Sebastian Meyer. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Esther Maria Furrer is a distinguished inventor whose work in antibody research has led to significant advancements in therapeutic applications. Her contributions continue to impact the field positively, showcasing her dedication to innovation and scientific progress.

Profile summary based on public USPTO records.